| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -190.1% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 3.6 | n/a |
| Pr/Book | 8.7 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 25.0% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 0.96 | (1.05) | (12.71)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 1.15 | (4.14) | (8.05)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 1.43 | (5.75) | (6.18)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 2.16 | (7.02) | (7.32)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 2.70 | (5.08) | (2.53)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Collaboration with Thermo Fisher | 04-Dec-2025 | 07:00 | RNS |
| Approval of CARDIO inCode-score in New York state | 03-Dec-2025 | 07:00 | RNS |
| Publication of Landmark Study in JACC: Advances | 27-Oct-2025 | 07:00 | RNS |
| GENinCode lowers outlook, shares slide | 30-Sep-2025 | ShareCast |
| GENinCode H1 revenues grow, losses unchanged YOY | 26-Aug-2025 | ShareCast |
| GENinCode enters collaboration with US Family He... | 20-Sep-2024 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 3.25p |
| Change Today | -0.15p |
| % Change | -4.41 % |
| 52 Week High | 5.80p |
| 52 Week Low | 1.40p |
| Volume | 381,907 |
| Shares Issued | 286.88m |
| Market Cap | £9.32m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 11:20 | 50,000 @ 3.12p |
| 10:59 | 51,494 @ 3.20p |
| 10:57 | 50 @ 3.20p |
| 10:57 | 402 @ 3.20p |
| 10:57 | 100 @ 3.40p |
| CEO | Matthew Heaton Walls |
| CFO | Paul Andrew Peter Foulger |
| COO | Jordi Puig Gilberte |
You are here: research